We invest in the development of finished medicinal products and active pharmaceutical ingredients, focusing on effectiveness and quality compliance
Products
and
technologies
The technology development and implementation cases fall under the nosologies
Diabetes
Oncology
Neurology
Cardiology
Pain management
Gastroenterology
Reproductive Health
Respiratory system infections
Cancer products
Abiraterone Acetate
tablets
250 mg, 500 mg
API technology
Finished Formulation Technology
Everolimus
tablets
5 mg, 10 mg
API technology
Finished Formulation Technology
Lapatinib
tablets
250 mg
API technology
Finished Formulation Technology
Sunitinib
capsules
12.5 mg, 25 mg, 37.5 mg, 50 mg
API technology
Finished Formulation Technology
Sorafenib
tablets
200 mg
Finished Formulation Technology
Lenvatinib
capsules
4 mg, 10 mg
Finished Formulation Technology
Rucaparib
tablets
300 mg
API technology
Finished Formulation Technology
Pomalidomide
capsules
1 mg, 2 mg, 3 mg 4 mg
Finished Formulation Technology
Enzalutamide
capsules
40 mg, 80 mg,
API technology
Finished Formulation Technology
Enzalutamide
tablets
160 mg
API technology
Finished Formulation Technology
Apalutamide
tablets
60 mg
API technology
Finished Formulation Technology
Rucaparib
tablets
200 mg, 250 mg
Finished Formulation Technology
Erlotinib
tablets
25 mg, 100 mg, 150 mg
API technology
Finished Formulation Technology
Gefitinib
tablets
250 mg
API technology
Finished Formulation Technology
Nilotinib
capsules
150 mg, 200 mg
Finished Formulation Technology
Ibrutinib
capsules
140 mg
Finished Formulation Technology
Axitinib
-
1 mg, 5 mg
API technology
Finished Formulation Technology
Imatinib
tablets
100 mg, 400 mg
API technology
Finished Formulation Technology
Olaparib
tablets
50 mg, 100 mg, 150 mg
Finished Formulation Technology
Capecitabine
tablets
150 mg, 500 mg
API technology
Finished Formulation Technology
Fulvestrant
injection
250 mg, PFS
Finished Formulation Technology
Bortezomib
injection
3.5 mg
API technology
Finished Formulation Technology
Irinotecan
injection
40 mg, 100 mg, 300 mg
API technology
Finished Formulation Technology
Azacitidine
injection
100 mg
API technology
Finished Formulation Technology
Bendamustine
injection
25 mg, 100 mg
Finished Formulation Technology
Docetaxel
injection RTU
20 mg, 80 mg
Finished Formulation Technology
Pemetrexed
injection
100 mg, 500 mg
Finished Formulation Technology
Nab-paclitaxel
injection
100 mg
API technology
Finished Formulation Technology
Various
products
products
Edaravone
sublingual tablets
30 mg
API technology
Finished Formulation Technology
Obeticholic acid + ursodeoxycholic acid
MR tablets
5 mg + 500 mg
API technology
Finished Formulation Technology
Etoricoxib
gel
1%
API technology
Finished Formulation Technology
Remifentanil
Lyo powder for injection
1 mg, 2 mg, 5 mg
API technology
Finished Formulation Technology
Baloxavir
tablets
20 mg, 40 mg
API technology
Finished Formulation Technology
Diabetes products
Sitagliptin
tablets
25 mg, 50 mg,
100 mg
API technology
Finished Formulation Technology
Vildagliptin
tablets
50 mg
API technology
Finished Formulation Technology
Glipizide
ER tablets
5mg, 10 mg
API technology
Finished Formulation Technology
Glimepiride
tablets
1mg, 2mg
API technology
Finished Formulation Technology
Empagliflozin
tablets
10 mg, 25 mg
API technology
Finished Formulation Technology
Dapagliflozin
tablets
5 mg, 10 mg
API technology
Finished Formulation Technology
Canagliflozin
FC tablets
100 mg, 300 mg
API technology
Finished Formulation Technology
Metformin
PR tablets
500 mg, 1000 mg
Finished Formulation Technology
Metformin + sitagliptin
ER tablets
500/1000 mg + 50/100 mg
Finished Formulation Technology
Liraglutide
injection
18 mg / 3 ml
API technology
Finished Formulation Technology
Cardio-vascular products
Apixaban
tablets
2.5 mg, 5 mg
API technology
Finished Formulation Technology
Rivaroxaban
tablets
2.5 mg, 10 mg, 15 mg, 20 mg
API technology
Finished Formulation Technology
Pravastin + fenofibrate
capsules
40 mg + 160 mg
API technology
Finished Formulation Technology
Valsartan + amlodipine + hydrochlorthiazide
tablets
160/320 mg + 5/10 mg + 12.5/25 mg
API technology
Finished Formulation Technology
Metoprolol
ER tablets
25 mg
API technology
Finished Formulation Technology
Edaravone
injection
30 mg
API technology
Finished Formulation Technology
Sacubitril + valsartan
tablets
24 mg / 49 mg / 97 mg + 25 mg / 51 mg / 103 mg
API technology
Finished Formulation Technology
LET'S CREATE
TOGETHER!
TOGETHER!
